Use of Dermoscopy in Prognostication and Therapeutic Monitoring of Non-neoplastic Disorders

Dermoscopy has transformed from a toolprimarily used for assessing melanocytic and non-melanocytic skin tumors into an essential aid in general dermatology. Its application now extends to various ailments, such as infiltrative, pigmentary, inflammatory, and infectious dermatoses. Beyond facilitating early and accurate diagnosis, dermoscopy has gained recognition for its role in evaluating progression of disease and response to treatment. As a non-invasive imaging modality, it offers a significant advantage over histopathology, particularly in long-term disease monitoring. Recent studies highlight its ability to detect subtle changes indicative of therapeutic efficacy, allowing for timely modifications in management. By integrating dermoscopic evaluation into routine clinical practice, dermatologists can enhance diagnostic precision, predict disease prognosis, and refine treatment approaches, ultimately improving patient outcomes. This review explores the growing relevance of dermoscopy in non-neoplastic dermatoses, emphasizing its value in prognostic assessment and therapeutic monitoring.